Amid the current chikungunya outbreak, Jinhao Pharmaceutical's precise testing supports scientific prevention and control
Release time：2025.07.25
Night of July 21, The Guangdong Provincial Center for Disease Control and Prevention issued an "Appeal to Citizens," which pointed out that Guangdong Province has experienced an outbreak of chikungunya fever, and the dengue fever epidemic has also entered a rapid rise period. 。
On July 22, at a press conference held in Geneva, World Health Organization experts issued a warning about mosquito-borne chikungunya fever , reminding countries to prepare and avoid large-scale outbreaks. 。
According to the report from the Health and Wellness Bureau of Shunde District, Foshan City, Guangdong Province, on July 8, a local outbreak of chikungunya fever caused by imported cases was detected in Shunde District, Foshan City, Guangdong Province. As of July 23, 2025, Shunde District has cumulatively reported confirmed cases of chikungunya fever. 3317 cases 。
In addition, Lu Hongzhou, director of Shenzhen Third People's Hospital, stated in a public interview that the epidemic in Shunde District has shown obvious spillover. Currently, Shenzhen City has reported one confirmed case imported from Foshan, and two other Foshan cases have activity trajectories in Shenzhen (one has already sought medical treatment).
Since the discovery of imported chikungunya virus infection cases and the outbreak spillover in Foshan, Guangdong Province, Beijing has also found imported cases. Experts from multiple disease control centers especially remind that people who have been to countries or regions with chikungunya fever outbreaks within the past 12 days, once experiencing symptoms such as fever, joint pain, or rash, should promptly visit formal medical institutions and proactively inform doctors of their travel history.
What is chikungunya fever?
Chikungunya fever is caused by the chikungunya virus and is transmitted through Aedes mosquitoes (commonly known as tiger mosquitoes) bites. It is an acute infectious disease that can infect people of all ages.
The incubation period of chikungunya fever is generally 1 to 12 days, with symptoms usually appearing within 3-7 days. Typical clinical manifestations include fever, joint pain/arthritis, and rash. Symptoms of chikungunya fever are similar to those of dengue fever and Zika virus disease , which makes chikungunya fever easily misdiagnosed.
Within 2-5 days after onset, 2-5天 high-titer viremia can develop, making the patient highly infectious and capable of infecting vector Aedes mosquitoes, thereby spreading the disease. Like dengue fever, there are many asymptomatic infections , which can serve as sources of infection. 。
Diagnosis of chikungunya fever
According to the "Technical Guidelines for the Prevention and Control of Chikungunya Fever (2025 Edition)" issued by the Chinese Center for Disease Control and Prevention 《基孔肯雅热防控技术指南（2025年版）》 and the "Diagnosis and Treatment Plan for Chikungunya Fever", the diagnosis of chikungunya fever requires a combination of epidemiological data, clinical manifestations, and laboratory diagnosis. Laboratory tests include serological tests (antibody detection) and pathogen tests (nucleic acid detection).
To respond to the chikungunya fever epidemic, Jinhao Pharmaceutical has independently developed and produced 的 chikungunya virus nucleic acid detection kits (fluorescent PCR method), chikungunya virus IgM/IgG antibody detection kits (colloidal gold method), chikungunya virus antigen detection kits (colloidal gold method) and more vector-borne pathogen detection kits.
Through rapid and accurate laboratory testing, achieve "early detection, early reporting, early isolation, early treatment" 早发现、早报告、早隔离、早处置” effectively reducing the risk of epidemic spread.
Copyright © 2025 Beijing Kinghawk Pharmaceutical Co., Ltd. All rights reserved.